FeaturedNeurologyNeuroscience·March 23, 2022·3 min readIntake of FDA-Approved Drug Modulates Disease Progression in Alzheimer’s ModelNiaspan, an FDA-approved drug, limits disease progression in lab models of Alzheimer's disease.Read More
